Dong Wang Awarded Max-Kade-Fellowship

Dong Wang, M.D., a postdoctoral fellow in the Transplant and Stem Cell Immunobiology (TSI), has been awarded the Max-Kade-Fellowship in April 2017. The Max Kade Foundation supports initiatives which promote international understanding by sponsoring exchange programs between Germany, Austria and the United States such as post-doctoral research exchange programs, visiting faculty exchange programs, and exchange programs of undergraduate and graduate students both here and abroad. Dr. Wang will investigate the behavior and fate of stem cell derived cardiomyocytes. 

About Dong Wang, M.D.

Dr. Wang's primary clinical interest is contemporary interventional methods for treating coronary artery disease and valvular heart disease. He is dedicated to the early detection of heart diseases and investigation of new therapeutic mechanism. He focuses on integrating the most recent laboratory advances into clinical paradigm.

Dr. Wang is dedicated to increase the understanding of genetic and molecular pathways in vascular smooth muscle cells, which underlies the evolution of myointima hyperplasia and in-stent restenosis. Myontimal hyperplasia is a pathological process after vessel injury and characterized by abnormal proliferation of smooth muscle cells and subsequent luminal obliteration. The overall goal is to identify potential targets to prevent disease development and increase the success of treatments for coronary heart disease.

In addition, Dr. Wang has special interest in stem cell based regenerative medicine. He aims to understand the immunological barriers that currently impede the successful application of cell-based regenerative therapy.